Biosensors for Carcinoembryonic Antigen Detection for Future Prospective: A Review

Abstract

Recently, the increasing number of cancer disease is a challenge for researchers and lots of people died from this cause. Only one solution for this disease is proper diagnosis and detection of the Carcinoembryonic Antigen (CEA) in the human body system which extensively reduces cancer mortality and saves lives for human beings. For that reason, the biologist developing the biosensor detection of CEA is mandatory because they are easy to utilize, handy, and can-do treatment in actual time. The biosensors play a significant role in the early signs of disease. These can be employed for the danger judgment, diagnosis, and projection for the forecast of treatment effectiveness, toxicity, and repetition. This review article systematically bestows a brief overview of the development of biosensors and the identification of CEA and its various types. Numerous approaches to be used for the recognition of cancer biomarkers, such as labelfree approach, electrochemical, mass-based transduction, and optical and analytical performance of several biosensors, explore the unsolved difficulties and future challenges in the development of cancer biomarkers.